Initial Treatment for Elevated TSH
For patients with elevated TSH, the initial treatment is levothyroxine (T4) therapy for those with TSH persistently >10 mIU/L or for symptomatic patients with any degree of TSH elevation. 1
Assessment and Diagnosis
- Before initiating treatment, confirm elevated TSH with repeat testing after 3-6 weeks, as 30-60% of high TSH levels normalize on repeat testing 1
- Measure both TSH and free T4 to distinguish between subclinical hypothyroidism (normal free T4) and overt hypothyroidism (low free T4) 1
- Low TSH with low free T4 suggests central hypothyroidism, which requires different evaluation and management 1
Treatment Algorithm Based on TSH Levels
TSH >10 mIU/L
- Initiate levothyroxine therapy regardless of symptoms 1
- This level of elevation carries higher risk of progression to overt hypothyroidism (approximately 5% per year) 1
- Treatment may prevent complications of hypothyroidism in patients who progress 1
TSH 4.5-10 mIU/L and Asymptomatic
- Continue monitoring TSH and free T4 every 4-6 weeks without immediate treatment 1
- Consider monitoring before treating to determine if there is recovery to normal within 3-4 weeks, especially if this might be recovery phase of thyroiditis 1
TSH 4.5-10 mIU/L with Symptoms
- Prescribe thyroid hormone supplementation for symptomatic patients with any degree of TSH elevation 1
- Consider a trial of levothyroxine therapy with assessment of symptom response after 3-4 months 2, 3
- If no symptom improvement occurs after reaching normal TSH levels, consider discontinuing therapy 3
Special Populations Requiring Treatment Regardless of TSH Level
- Pregnant women or those planning pregnancy 1
- Patients with severe symptoms affecting quality of life 1
Levothyroxine Dosing Guidelines
Initial Dosing
- For patients <70 years without cardiac disease or multiple comorbidities: Full replacement dose of approximately 1.6 mcg/kg/day 1, 4
- For patients >70 years or with cardiac disease/multiple comorbidities: Start with lower dose of 25-50 mcg/day and titrate gradually 1
- Take on an empty stomach for optimal absorption 2
Dose Adjustments and Monitoring
- Monitor TSH every 6-8 weeks while titrating hormone replacement 1
- Adjust dose to achieve TSH within reference range (target 0.5-2.0 mIU/L for most adults) 5, 3
- Once adequately treated, repeat testing every 6-12 months or if symptoms change 1
- Free T4 can help interpret ongoing abnormal TSH levels during therapy, as TSH may take longer to normalize 1
Common Pitfalls and Considerations
Drug interactions: Many medications can affect levothyroxine absorption or metabolism 4
Overtreatment risks: Excessive levothyroxine can lead to 4, 5
- Atrial fibrillation
- Osteoporosis and increased fracture risk
- Symptoms of thyrotoxicosis (tachycardia, tremor, sweating)
Undertreatment risks: Inadequate replacement may result in 4
- Persistent hypothyroid symptoms
- Adverse effects on cardiovascular function, lipid metabolism, and quality of life
Compliance issues: Poor adherence is a common cause of treatment failure 5
- Development of low TSH on therapy suggests overtreatment or recovery of thyroid function; dose should be reduced or discontinued with close follow-up 1
By following this structured approach to treating elevated TSH, clinicians can optimize patient outcomes while minimizing risks associated with both under- and overtreatment of thyroid dysfunction.